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To the Editor:
Proteolysis of cell surface- and extracellular matrix mole-
cules (ECM) is intrinsically linked to the physiological cell
function and fate (Hengartner, 2000; Brinckerhoff and Mat-
risian, 2002). The regulation of the proteolytic processes is
achieved primarily through coordinated interactions be-
tween proteinases and their inhibitors. We previously re-
ported that matrix metalloproteinases (MMP) are involved
strongly in the pathogenesis of venous leg ulcers (Herouy
et al, 1998, 2000). Tissue inhibitor of metalloproteinase-3
(TIMP-3) belongs to a family of secreted proteins that reg-
ulate the activity of several metalloproteinases and is an
inducer of apoptotic cell death (Woessner, 2001). The pro-
death domain of TIMP-3 resides in its N-terminal region and
apoptosis is induced by the activation of a signaling cas-
cade involving caspase-8 and caspase-9 (Bond et al, 2000).
Venous leg ulcers account for the majority of chronic
wounds and are a common cause of morbidity, with a sig-
nificant incidence in the population of the western world.
The underlying mechanisms leading to such drastic cellular
changes of venous ulcerations have been a matter of de-
bate. Pressure-damaged capillary vessels with leakage of
fibrinogen, release of toxic metabolites by accumulated le-
ukocytes or cytokine-mediated fibrin cuff formation have
been suggested (Herrick et al, 1992). Due to the impaired
oxygen supply, all three hypotheses are supposed to result
into necrotic events; however, venous leg ulcers lack such
clinical signs. Although imbalanced proteolytic activity sup-
ports strongly the progression of venous leg ulcers, the
factors determining cell fate have not been discussed until
now. Thus, we investigated in the following experiments
whether apoptosis plays a role in the pathogenesis of ve-
nous leg ulcers.
Here we determined the protein expression of TIMP-3,
FAS/CD95, and BCL-2 by immunohistochemistry, the ca-
spase-8 and caspase-9 protein expression and activity by
caspase activity assays as well as the DNA-fragmentation
by positive DNA in situ nick end-labeling (TUNEL). All anal-
yses were performed in tissue specimens of venous leg ul-
cers (n¼ 24; mean age 60.2 SD  8.3; mean wound size
23.6 cm2) and age- and sex-matched healthy skin controls
(n¼ 24; mean age 61.7 SD  9.6). All specimens were ob-
tained from different patients within the ulcer ground. All
patients received solely compression therapy before biopsy
specimens were taken. Staining with anti-TIMP-3 displayed
cuffed pattern of vessel staining and an intense signal
around collagen bundles in the reticular dermis of venous
leg ulcers (Fig 1a), whereas weak immunoreactivity was
seen in healthy skin (Fig 1a). Staining of acute wounds
showed no expression of TIMP-3 and were therefore com-
parable to the condition of healthy skin. Staining with Fas/
CD95 showed an intense cellular immunoreactivity in le-
sions (Fig 1a) in comparison with healthy controls (data not
shown), whereas BCL-2 showed weak cellular immunore-
activity in leg ulcer lesions in comparison with healthy con-
trols (data not shown). Immunoblotting with caspase-8 and
caspase-9 antibodies revealed expression of the proca-
spase form for caspase-8 and caspase-9 in healthy skin,
whereas these forms were less immunoreactive in lesional
skin of venous leg ulcers (Fig 1b). In these patients, the
processed forms as well as the active subunits of these
apoptosis regulators were found as prominent bands. Les-
ional skin displayed increased activity for caspase-8
(po0.001) and caspase-9 (po0.001) in comparison with
healthy controls measured by caspase activity assays (Fig 1c).
Moreover, quantification of apoptotic cells by TdT-me-
diated incorporation of dUTP into fragmented DNA (TUNEL)
revealed significantly elevated apoptotic cell death in venous
leg ulcers in comparison with healthy controls (po0.001)
(Fig 1c). There were no significant differences in the TUNEL
assay in healthy skin in comparison with biopsies taken
1.5 cm distance from the edge of the ulcer (data not shown).
Venous leg ulcers are characterized by loss of epidermal
and partly dermal cellular structures. These drastic mor-
phological changes were thought to be caused by impaired
oxygen supply or reactive toxic metabolites (Herrick et al,
1992). Our results suggest that TIMP-3 could contribute
strongly to the pathogenesis of this disease through induc-
tion of apoptosis in venous leg ulcers by using the caspase
activation cascade in Fas-receptor pathway. It is well known
that TIMP-3 mediates ligand binding-induced trimerization
of death receptors (Fas/CD95), resulting in recruitment of
the receptor-specific adapter protein Fas-associated death
domain (FADD), which activates caspase-8 (Bond et al,
2000). Tumor necrosis factor-a receptors has, however,
been also implicated as prodeath receptor in colon cancer
cells. Therefore further investigations are required as to how
this pathway additionally plays a role to induce apoptosis in
venous leg ulcers. Activated caspase-8 propagates the
apoptotic signal by breakdown of the BH3 Bcl2-interacting
protein. This leads to the release of cytochrome c from mi-
tochondria and triggers activation of caspase-9 and a com-
plex with dATP and Apaf-1 (Fig 1d ). Activated caspase-9
further regulates ‘‘downstream caspases’’ and ultimately
induces the programmed death cell via death substrates
(Kroemer and Reed, 2000). In summary, we provide here
circumstantial evidence that venous leg ulcers could be the
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result of an apoptotic signaling pathway, which might be
induced through a TIMP-3-mediated inhibition of proteinase-
dependent ECM degradation. These results suggest that
controlling programmed cell death may have therapeutic
potential in preventing venous leg ulceration.
University of Freiburg has approved the experiments and
all patients undergoing the experiments gave their informed
written consent. All experiments performed adhere to the
Declaration of Helsinki Principles.
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Figure 1
(a) Immunhistochemical staining of TIMP-3 and Fas/CD95 in venous leg ulcers. TIMP-3 displays intense immunoreactivity in dermal layers (black
arrowheads) and in perivascular regions of lesional skin (white arrowheads), whereas weak signal was detected in the dermal layer of healthy skin (n¼ 6
for venous leg ulcers; n¼6 for controls). Fas/CD95 displays intense immunoreactivity in the cellular regions (white arrowheads), whereas weak signal was
detected in healthy skin (n¼6 for venous leg ulcers; 6 for controls). Representative photographs from one patient is shown. Scale bar¼ 100 mm. (b)
Protein analysis of caspase-8 and caspase-9 was performed by western blot using primary antibodies. Immunoblotting reveals elevated immuno-
reactivity for the active subunits of caspase-8 and caspase-9 in venous leg ulcers (1) in contrast to healthy controls (2) (n¼5 for venous leg ulcers; n¼ 5
for controls). (c) Quantification of apoptotic cells in venous leg ulcers (1) in comparison with controls (2) (left bars). Apoptotic cell death was measured by
TdT-mediated incorporation of dUTP into fragmented DNA (TUNEL), which was measured in a liquid scintillation counter. Rate of apoptosis was
significantly elevated in lesional skin in comparison with healthy controls (t test po0.001). Control TUNEL reactions in the absence of TdT enzyme
yielded no staining. Values are given as specific apoptosis  SD (n¼ 7 for venous leg ulcers; n¼ 7 for controls). Quantification of the caspase-8 and
caspase-9 activity shows significantly elevated activity levels for both caspases in lesional skin (1) in comparison with healthy controls (2) (t test
po0.001) (right bars). (d) Pathway for TIMP-3-mediated caspase activation and apoptosis. The extrinsic pathway for caspase activation is mediated by
TIMP-3 and is triggered through an FADD-dependent (Fas/CD95) type II apoptotic pathway. These proteins recruit adapter proteins to their cytosolic
domains, such as FADD, which then bind pro-caspase-8. The intrinsic pathway is induced by release of cytochrome c (Cyto-c) frommitrochondria, which
is induced by elevated levels of pro-apoptotic Bcl-2 family proteins such as Bax or Bak. In the cytosol, cytochrome c binds and activates Apaf-1, which
then binds and activates pro-caspase-9. Active caspase-9 can directly cleave and activate ‘‘downstream caspases’’, triggering apoptosis ultimately.
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